Which statement about serum markers is true for hepatic hemangioma?

Prepare for Liver Disease and Tumors Test with tailored flashcards and questions. Get detailed explanations and improve your knowledge. Ace the medical student exam!

Multiple Choice

Which statement about serum markers is true for hepatic hemangioma?

Hepatic hemangioma is a benign vascular liver lesion, and there is no serum marker that uniquely identifies it. Alpha-fetoprotein is not elevated in hemangioma and is instead used to screen for hepatocellular carcinoma or certain germ cell tumors. CA 19-9 is a marker more related to pancreaticobiliary disease and is not diagnostic for liver hemangioma. Liver enzymes are not a defining feature and are usually normal, though they can be mildly elevated for other reasons. Because no specific serum test exists, imaging characteristics on ultrasound, CT, or MRI are used to diagnose hemangioma rather than a blood marker.

Hepatic hemangioma is a benign vascular liver lesion, and there is no serum marker that uniquely identifies it. Alpha-fetoprotein is not elevated in hemangioma and is instead used to screen for hepatocellular carcinoma or certain germ cell tumors. CA 19-9 is a marker more related to pancreaticobiliary disease and is not diagnostic for liver hemangioma. Liver enzymes are not a defining feature and are usually normal, though they can be mildly elevated for other reasons. Because no specific serum test exists, imaging characteristics on ultrasound, CT, or MRI are used to diagnose hemangioma rather than a blood marker.

More practice questions